Clinical Trial Update: Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

View source ↗

Summary

Clinical trial update for nine consecutive infusions of Remicade (infliximab) in psoriatic arthritis; results for Study P04264 have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Psoriatic | Status: COMPLETED | Results posted: 2011-07-29